STAB
Statera Biopharma, Inc. Common Stock
STAB
STAB
Delisted
STAB was delisted on the 11th of January, 2023.
39 hedge funds and large institutions have $5.45M invested in Statera Biopharma, Inc. Common Stock in 2013 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 9 increasing their positions, 8 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
33% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 6
Holders
39
Holding in Top 10
–
Calls
$137K
Puts
$25K
Top Buyers
| 1 | +$112K | |
| 2 | +$103K | |
| 3 | +$54K | |
| 4 |
VKH
Virtu KCG Holdings
New York
|
+$50.5K |
| 5 |
AW
ACG Wealth
Atlanta,
Georgia
|
+$37K |
Top Sellers
| 1 | -$468K | |
| 2 | -$44.5K | |
| 3 | -$31K | |
| 4 |
Wells Fargo
San Francisco,
California
|
-$12.9K |
| 5 |
Morgan Stanley
New York
|
-$9.39K |